Source / episode info
- **Episode:**467
- **Title:**Divine Intervention Episode 467: The Clutch Cervical Cancer Podcast (for Step 1-3)
- **Published:**2023-06-29
- Source:Episode page
One-liner
This episode provides a comprehensive review of cervical cancer, covering its pathophysiology (uremic complications), the molecular mechanism of HPV oncogenesis (E6/p53 and E7/RB), current screening guidelines (Pap smear vs. co-testing), colposcopy indications, and the workup of atypical glandular cells.
High-yield summary
- Molecular Mechanism: High-risk HPV types (especially 16 and 18) cause malignancy by producing E6 and E7 proteins. E6 targets and degrades the tumor suppressor protein p53, while E7 targets and inactivates RB.
- Screening Guidelines: The preferred screening strategy for women aged 30–65 is Pap smear + HPV co-testing every five years, rather than Pap smears alone. Screening should continue past age 65 if the patient has high risk factors (e.g., HIV, DES exposure).
- Atypical Glandular Cells (AGC): AGC requires a thorough workup of the entire reproductive tract: endometrial biopsy, endocervical curettage, and colposcopy.
- Colposcopy Indications: Colposcopy is mandatory if Pap smear shows HSIL, typical glandular cells, ASC-H, positive high-risk HPV, or multiple positive ASC-US.
- DES Exposure: Exposure to Diethylstilbestrol (DES) significantly increases the risk of clear cell adenocarcinoma in the vagina and cervix.
- Procedures & Complications: LEEP/Cold snare procedures are highly effective but carry a risk of cervical incompetence, which can present as painless second-trimester pregnancy loss.
Learning objectives
- Describe the molecular mechanism by which high-risk HPV types induce cervical carcinogenesis (E6/p53, E7/RB).
- Apply current guidelines for Pap smear screening frequency and co-testing in different age groups (21–65 years).
- Identify clinical scenarios requiring immediate colposcopy based on cytology or molecular testing results.
- Outline the comprehensive workup required when atypical glandular cells are identified during cervical screening.
- Recognize the specific risks associated with DES exposure and advanced gynecologic malignancies.